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Abstract
Background: Detecting functional variants contributing to diversity of behaviour is crucial for dissecting genetics
of complex behaviours. At a molecular level, characterisation of variation in exons has been studied as they are
easily identified in the current genome annotation although the functional consequences are less well understood;
however, it has been difficult to prioritise regions of non-coding DNA in which genetic variation could also have
significant functional consequences. Comparison of multiple vertebrate genomes has allowed the identification of
non-coding evolutionary conserved regions (ECRs), in which the degree of conservation can be comparable with
exonic regions suggesting functional significance.
Results: We identified ECRs at the dopamine receptor D4 gene locus, an important gene for human behaviours.
The most conserved non-coding ECR (D4ECR1) supported high reporter gene expression in primary cultures
derived from neonate rat frontal cortex. Computer aided analysis of the sequence of the D4ECR1 indicated the
potential transcription factors that could modulate its function. D4ECR1 contained multiple consensus sequences
for binding the transcription factor Sp1, a factor previously implicated in DRD4 expression. Co-transfection
experiments demonstrated that overexpression of Sp1 significantly decreased the activity of the D4ECR1 in vitro.
Conclusion: Bioinformatic analysis complemented by functional analysis of the DRD4 gene locus has identified a) a
strong enhancer that functions in neurons and b) a transcription factor that may modulate the function of that
enhancer.
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Background
Complex behaviours are likely to be generated in part by
how, where, when and by how much proteins are involved
in neurotransmission. A key to understanding how such
expression patterns are generated is to identify transcrip-
tional regulatory domains for a particular gene. Compara-
tive genetics allows the identification of such domains
[1,2] and in this communication we have applied such a
strategy to identify regulatory domains of the dopamine
receptor D4 (DRD4). The DRD4 gene is involved in the
regulation of social and cognitive phenotype of modern
humans and it is preferentially expressed in the prefrontal
and cingulate cortices [3-5], key centres for processing of
complex behaviour and cognition. In these regions, the
DRD4 protein acts as a regulator of dopamine levels,
where mis-expression of DRD4 has also been associated
with the onset of cognitive, behavioural and personality
disorders e.g., shyness, ADHD, addiction and Parkinson’s
disease [6-9]. Several polymorphisms exhibiting cis regula-
tory properties have been identified in this gene. However,
in spite of the interest in the DRD4 gene and its potential
importance for pharmacogenetics, the regulatory machin-
ery behind appropriate spatial-temporal gene expression
remains to be elucidated.
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permitted comparisons that reveal strong conservation of
non-coding regions (evolutionary conserved regions or
ECRs) between distantly related vertebrate species (e.g.,
between human and mouse or human and fish). Such
conservation has been suggested to indicate that a given
ECR could act as either a cis regulator of gene expression,
alter post-transcriptional modifications or both [1,2]. In
vertebrates ECRs have been identified in many genes
involved in development [10-12] and behaviour [13].
To search for ECRs that may play a role in regulating
the DRD4 gene expression, we conducted a multiple
comparison of 28 vertebrate genomes at this locus using
the UCSC browser (http://genome.ucsc.edu). The tran-
scriptional activity of the most conserved ECR (D4ECR1)
identified at the DRD4 locus was tested in vitro. Here we
assessed the ability of this ECR fragment to support luci-
ferase reporter gene expression in primary cultures of rat
neonate cortical tissue. These cells were chosen for the
analyses because prefrontal cortex (PFC) neurons have
been reported to express the endogenous DRD4 gene
during prenatal and early postnatal development in mod-
ern humans [3,4]. The expression of the DRD4 gene was
also confirmed by RTPCR of cDNA extracted from tissue
sections (additional file 1).
Furthermore, we assessed whether this D4ECR1 was
subject to regulation by Sp1, a transcription factor which
has multiple potential consensus sequences in this ECR
and has been suggested as a candidate regulator for DRD4
gene expression [14]. Our data demonstrate that this
bioinformatics approach is capable of identifying regula-
tory domains and the transcription factors that modulate
them.
Results
Identification of an ECR in the DRD4 gene of mammals
Examination of the DRD4 gene and flanking regions using
the 28 way most conserved option of the conservation tool
on the UCSC browser (limited by neighbouring genes at
10 kb upstream and 3.5 kb downstream) revealed the pre-
sence of one strong ECR in its first intron (henceforth
referred to as D4ECR1, located in chr11: 628420 - 628493,
74 bp in the human genome [hg18 2006 assembly]). Loca-
tion is shown in Figure 1A.
Examination of the peak of conservation generated
showed that a highly homologous sequence to that of
the human D4ECR1 was found in 7 other mammalian
genomes: Pan troglodytes (chimpanzee), Macaca
mulatta (rhesus macaque), Mus musculus (mouse),R a t -
tus norvegicus (rat), Cavia porcellus (guinea pig), Echi-
nops telfairi (tenrec) and Canis familiaris (dog). Due to
the lack of sequencing across the D4ECR1 locus other
vertebrate genomes, it was impossible to determine if
this sequence was conserved across vertebrates.
The TFBS in the mammalian D4ECR1 sequences were
identified by AliBaba 2.1 (Table 1). Briefly, AliBaba is a
program for predicting binding sites of transcription fac-
tors in an unknown DNA sequence; it uses the binding
sites collected in TRANSFAC (4.0). This analysis identi-
fied 7 conserved binding sites for different types of TFs
between the human and mouse D4ECR1 (Table 1).
These TFs include: Sp1, GATA1, AP2alpha, Oct1, NF1,
GR and T3Ralpha, whereby the most common binding
site found in the D4ECR1 sequence was for the TF Sp1
(Figure 1B).
Functional analysis of the human D4ECR1 demonstrated
its ability to support differential luciferase expression in
cultures of neonate frontal cortex
The potential transcriptional activity of a DNA fragment
including the human D4ECR1 was validated in a repor-
ter gene assay (Figure 2). The D4ECR1p construct was
able to act as an enhancer of pGL3p reporter gene
expression in primary cultures of frontal cortex obtained
from 2 and 5 day old male Wistar rats. In these cell cul-
tures, the activity supported by the D4ECR1p (4.9 fold)
was significantly higher than that supported by the
unmodified pGL3p control plasmid (Student’s T-test,
pGL3p vs. D4ECR1 2+5 days, p < 0.001, indicated by ***
in Figure 2).
D4ECR1 enhancer activity is regulated by overexpression
of Sp1 in vitro
The identification of multiple Sp1 sites in the D4ECR1
sequence (Figure 1B) may be of importance because this
TF has been previously found to bind other proposed
cis regulators of the human DRD4 gene [14,15]. The co-
transfection experiment (Figure 3) demonstrated that
overexpression of Sp1 can modulate the enhancer activ-
ity of D4ECR1p in dissociated cultures of neonate rat
frontal cortex at age 2 days, whereby both concentra-
tions of Sp1 tested had a repressing effect on the tran-
scriptional activity of the D4ECR1p.
In the graph the basal transcriptional activities of the
D 4 E C R 1 pa n dp G L 3 pp l a s m i d sw e r en o r m a l i s e dt o
100% to express the effect of co-transfecting with Sp1 as
percentages of repression. In brief, Sp1 was found to
repress the activity of both the unmodified pGL3p and
D4ECR1p constructs; however, this effect was only sta-
tistically significant for the D4ECR1p. (Student’s T-test:
pGL3p vs. pGL3p+ 0.5 μgo fS p 1p =0 . 1 9a n dv s .1μg
of Sp1, p = 0.46). There was no significant difference in
the levels of repression of D4ECR1p induced by the two
concentrations of Sp1. In brief, 0.5 μg of Sp1 repressed
the D4ECR1p activity in 77.5% (equal to 0.165 fold
increase, p = 0.005 [**]) and 1 μg of Sp1 repressed
D4ECR1p activity in 83.5% (equal to 0.225 fold increase,
p = 0.003 [**]).
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This study aimed to identify potential transcriptionally
active non-coding ECRs in the DRD4 gene locus of
mammals, using a comparative genomic analysis com-
plemented and validated by reporter gene analysis. The
analyses conducted demonstrated that there is at least
o n eE C Ri nt h eD R D 4g e n eo fm a m m a l s( F i g u r e1 A )
that exhibited transcriptional activity in frontal cortex
cultures of neonate rat (Figure 2). Furthermore, in our
analyses the activity of the D4ECR1p construct was
Figure 1 1A. Evolutionary conserved regions (ECRs) in the DRD4 gene locus of mammals. The conservation of non-coding regions in the
DRD4 locus and flanking regions was obtained using the conservation tool of the UCSC browser, set to identify most conserved areas amongst
28 species. Neighbouring genes SCT and DEAF1 delimited the region analysed. One conserved peak (D4ECR1) in the first intron of DRD4 gene
was selected for study. The alignment shows conservation of the sequence amongst 8 mammals. Dashed lines indicate no alignment. Figure 1B.
Sp1 binding sites (TFBS) found in the human D4ECR1 sequence. The Alibaba 2.1 program identified 5 Sp1 sites within the sequence of the
human D4ECR1 sequence (highlighted in bold font and underlined).
Table 1 TFBS in different mammalian D4ECR1 as identified by AliBaba 2.1.
Species Putative TFBS in the mammalian D4ECR1 sequences
Human Sp1, GATA1, C/EBPa, AP2a, D1, MIG1, E1, SRF, Oct1, CoS, NF1, GR, T3Ra, myogenin.
Chimpanzee Sp1, C/EBPa, D1, E1, SRF, Oct1, CoS, NF1, GR, T3Ra, myogenin.
Rhesus macaque Sp1, C/EBPa, D1, PU.1, FTz, E1, SRF, Oct1, CoS, NF1, GR, T3Ra.
Rat Sp1, Oct1, YY1, RAP1, NF1, Oct1, COUP, GR.
Mouse Sp1, GCN4, Oct1, C/EBPa, GAL4, Zen1, NF1, AP2a, GATA1, AP1, COUP, GR, T3Ra.
Guinea pig Sp1, GATA1, NF, AP2a, Adf1, NF1, HNF1, GR, myogenin.
Dog Sp1, NF1, CTF, NF, C/EBPa.
Tenrec Sp1, NF1, PU.1, Fra2, C/EBPa, CRE-BP1, USF, NF1, c-Jun, MyoD, AP2a, REV-ErBAa, ER.
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bind to the D4ECR1, was over-expressed (Figure 3).
The results suggest that D4ECR1 could act as a regula-
tor of DRD4 gene expression in the CNS. Analysis of the
in vitro regulatory role of the human D4ECR1p construct
(Figure 2) showed that it supported high levels of reporter
gene expression in cultures of neonate rat frontal cortex.
We observed (data not shown) that the transcriptional
effects of the D4ECR1p were distinct in the cultures
obtained from rats at different ages. This might be relevant
as dopaminergic activity and DRD4 mRNA levels fluctuate
during the first days of postnatal development in the cere-
bral cortex of rats [4,16-18].
DRD4 expression in the prefrontal cortex is constantly
being modified in vivo in early postnatal development as
demonstrated by previous reports (e.g. ref. [18,19]). Thus,
it is possible that the D4ECR1 could be one domain that
mediates such differences in regulation at this time, how-
ever there any many other regulators and domains that
are likely to contribute to DRD4 expression. The varia-
tion in the activity of the D4ECR1p at these times is likely
to be caused by interaction with transcription and growth
factors differentially expressed during this period of
development. Coincidentally, the expression of Sp1 has
also been documented to fluctuate in the first days of
postnatal development in the rat cerebral cortex [19].
The factors potentially binding to the D4ECR1
sequence (Table 1) indicate potential regulatory path-
ways operating on D4ECR1. In the present study, the
TF with the highest number of binding sites found in
the D4ECR1 sequence by Alibaba 2.1 was Sp1 (Figure
1B). Potential Sp1 binding sites have previously been
reported in various positions within the human DRD4
locus including: the 120 bp duplication and 27 bp dele-
tion in the 5’ region [20,21]; upstream of the promoter
region [22] and in the 48 bp VNTR of the 3
rd exon [15].
The binding of Sp1 to some of these elements has been
confirmed in vitro by EMSA [14,15]. Furthermore, Sp1
was found to be expressed in the frontal cortex of neo-
nate rats and has been implicated in the regulation of
dopaminergic systems in the rat brain [23]. For all these
reason we addressed Sp1 regulation of D4ECR1. The
results indicate that the D4ECR1p described here is also
responsive to Sp1 and could either individually, or in
concert with the other predicted Sp1 regulated domains
in the DRD4 gene modulate its expression (Figure 3).
However, Sp1 is not the only transcription factor that is
predicted to modulate function directed by D4ECR1 and
further work is required to address how these might
interact to modulate the enhancer function.
Conclusion
The DRD4 gene harbours a non-coding ECR region in its
first intron which exhibits characteristics of a cis regula-
tor of gene expression in mammalian neurons. Further-
more, combination of comparative genomics and in vitro
assays can be very helpful to identify novel regulatory ele-
ments in genes relevant to behavioural disorders and the
transcription factors that regulate their function
Methods
Identification of ECRs in the DRD4 gene
The UCSC browser (http://genome.ucsc.edu/) was used
to analyse the entire dopamine receptor D4 gene locus
(accession number L12397) and 10000 and 3500 bases
of the 5’ and 3’ regions respectively (extent between
DRD4 and flanking genes SCT and DEAF1, Figure 1A).
The browser was set to identify regions of conservation
amongst the genome of 28 vertebrates using the Verte-
brate Multiz Alignment & PhastCons Conservation.
In silico prediction of transcription factor binding sites
(TFBS) in the D4ECR1 sequence
In order to investigate which transcription factors (TFs)
were potentially interacting with identified conserved
regions, the sequences were subjected to in silico ana-
lyses, using the publicly available Alibaba 2.1 program.
Figure 2 The human D4ECR1 exhibits transcriptional activity in
dissociated cultures of neonate rat frontal cortex. D4ECR1 (1
μg) construct was transfected into dissociated cultures of frontal
cortex obtained from 2 and 5 days old Wistar rats under basal
conditions. The transcriptional activity of the D4ECR1 is different
from pGL3p alone. This effect was found to be significant (Student’s
T-test, p < 0.001, ***). Values obtained in three independent
experiments per triplicate (n = 9).
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sequences for TF based on the TRANSFAC 4.0 library
(from the biological database webpage http://www.bio-
base-international.com) using the following parameters:
Minimum matrix conservation (similarity between the
consensus binding site for a TF and a potential binding
site in the query sequence) 70%, minimum number of
homologous sites (the minimum number of sites of
which a matrix is build) = 4, factor class level (the clas-
sification of TFs in the TRASNFAC database is hier-
archical and include 6 levels, from family of
transcription factors to splice variants) = 4 and similarity
of the sequence to the matrix = 1.
Generation of the D4ECR1 reporter gene construct
In silico analysis of the DRD4 gene suggested presence
of one strong ECR in intron 1 (termed D4ECR1). The
D4ECR1 fragment identified was amplified by polymer-
ase chain reaction (PCR) from H. sapiens genomic
DNA (Novagen) using the following primers:
DRDR4ECR1-f 5’ggggtacccct act cga ggt ttc ccc ttg at 3’
and DRDR4ECR1-r 5’ ccgctcgagcg tat gaa gac cgt gcc
cag tg 3’. These primers were designed to encompass
the D4ECR1 and incorporate flanking restriction sites
for Xho I and Acc65I (bold in the primer sequences)
one at either end of the primer s ,t of a c i l i t a t ec l o n i n g
into the reporter gene vector pGL3p (Promega, UK),
thus yielding a PCR fragment of 239bp. Briefly, condi-
tions for PCR comprised: a reaction mix containing 100
ng of DNA template, 1 μMo fe a c hp r i m e r ,2 . 5u n i t s
Diamond DNA polymerase (Bioline), 1X Diamond poly-
merase buffer (Bioline), 0.2 mM of each dNTP, 2 mM
MgCl2, 1 M betaine and dH20 to a final volume of 50 μl
per reaction. The PCR was performed for 35 cycles con-
sisting of 55°C annealing step (1 min), 72°C extension
step (1 min), and a 95°C denaturing step (1 min) in a
Px2 thermal cycler (Thermo Scientific). The fragment
generated by PCR was subcloned into the pGEM-T vec-
tor (Promega, UK) by TA cloning and the sequence ver-
ified. It was then released by enzymatic digestion with
Xho I and Acc65 I and subsequently cloned into the
multiple cloning site of the pGL3p vector, which carries
a reporter gene, Firefly luciferase, driven by a minimal
SV40 promoter (Promega, UK).
Cell culture
All rats were used under local and national Schedule 1
guidelines. Primary rat frontal cortex cultures were
Figure 3 Sp1 represses the D4ECR1 expression in dissociated cultures of neonate rat frontal cortex. Transcriptional activities of D4ECR1
and control plasmid (pGL3p) were equalled to 100%. Both D4ECR1 and pGL3p plasmids were co-transfected with 2 concentrations of Sp1
expression vector (0.5 and 1 μg). Sp1 significantly down regulated transcriptional activity supported by D4ECR1 (Student’s T-test p ≤ 0.01 = **; n
= 9, 2 day old neonates). The effect of Sp1 over-expression was expressed as the percentage repression on basal transcriptional activity of
D4ECR1 and pGL3p.
Paredes et al. BMC Neuroscience 2011, 12:46
http://www.biomedcentral.com/1471-2202/12/46
Page 5 of 7prepared from 2 or 5 day old male Wistar rats. Briefly,
frontal cortices were collected in dissection solution
(HBSS [Invitrogen-Gibco] containing 100 units/ml of
penicillin and 100 μg/ml of streptomycin [Sigma-Aldrich
Ltd.]). The tissue was mechanically and enzymatically dis-
associated using 2 Pasteur pipettes of decreasing pore size
in 3 ml of trypsin/EDTA solution (0.025/0.02% [Sigma-
Aldrich Ltd.]). Dissociated cells were pelleted at 500 rpm
and washed (3 times) with medium I (DMEM, 10% FCS,
penicillin/streptomycin 100 units/ml, 100 μg/ml), resus-
pended and plated in poly-D-lysine (100 μl of 200 mg/ml)
coated 24 well plates (5 × 10
5 cells per well) containing
medium I (1 ml, without antibiotics) for 7 hours at 37°C in
a humidified CO2 environment. The culture medium was
changed to culture medium II (Neurobasal-A medium
[Invitrogen/Gibco], 2% B27 supplement, 2 mM GlutaMAX
Ia n d1μg/ml of gentamycin), and cells were incubated
overnight prior to transfection.
Transfection and Co-transfection assays
The human D4ECR1-reporter gene plasmid (DRECR1p) or
unmodified pGL3p vector (1 μg each) and pmLuc2 (Sea
pansy luciferase expression vector [Novagen], 10 ng per
1 μg of luciferase reporter gene plasmid) were transiently
co-transfected into primary cultures using ExGen 500
reagent (Fermentas) following manufacturers instructions.
The pmLuc2 vector was used to control for transfection
efficiency and enable standardisation of firefly luciferase
values. At 48 hours post transfection, cells were lysed with
40 μl of passive lysis buffer (Promega UK, Ltd.). Firefly luci-
ferase was quantified using the Dual Luciferase kit (Pro-
mega Ltd UK) following manufacturers instructions.
Average luciferase activity values were expressed as a ratio
to the reporter gene expression supported by unmodified
pGL3p. Standard deviation and standard errors were calcu-
lated based on 3 independent experiments (triplicate wells).
To determine the effects of co-expression of a specific
TF on the regulatory abilities of this D4ECR1, we trans-
fected the D4ECR1p (1 μg per well) with the renillin luci-
ferase plasmid pmLuc2 (1:100 ratio) and two different
concentrations (0.5 and 1 μg) of an expression vector car-
rying the full length cDNA of human Sp1, kindly donated
by Michael Bannon [24]. These constructs were delivered
into primary cultures of neonate rat frontal cortex
obtained from 2 days old rats as described above. In con-
trol experiments, the unmodified luciferase vector pGL3p
(+pmLuc2) was also co-transfected with the two concen-
trations of Sp1 to assess possible effects of Sp1 on the
backbone of the luciferase plasmid.
Additional material
Additional File 1: RTPCR gel of DRD4 mRNA from rat frontal cortex.
Agarose gel showing the RTPCR products of the DRD4 receptor
amplified from from sections of Wistar neonate rat brain frontal cortex.
Lane 1: 1 kb ladder, lane 2: negative control, lane 3: RTPCR conducted
with rat genomic DNA, lane 4: RTPCR amplification from rat brain cortex.
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